The Asia Pacific Hemodynamic Monitoring Devices Market would witness market growth of 6.2% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 774.5 thousand Units, showcasing a growth of 7.8% (2019-2022).
Hemodynamic monitoring devices monitor blood flow and heart function, which helps doctors determine a patient's cardiovascular condition and inform therapy choices. The development of novel minimally invasive and non-invasive systems, the rapid advancement of surgical procedure techniques, and the rising prevalence of respiratory, cardiovascular, and chronic obstructive pulmonary (COPD) diseases are just a few factors driving the expected growth of the market.
Additionally, hemodynamic monitoring systems are quickly gaining popularity due to the rising older population, the increasing need for accurate and effective monitoring of changes during and after surgery, and the increased awareness of early detection and management of linked diseases and conditions. During the forecast period, factors including the rising prevalence of lifestyle-associated disorders, rapid adoption of advanced hemodynamic monitoring devices in intensive care units, rising healthcare costs, and the expansion of healthcare infrastructure are expected to accelerate the market growth in terms of revenue. Future market expansion is expected to be fueled by increasing funding from public and private organizations and a strong focus on developing sophisticated, user-friendly, and cost-effective monitoring technologies.
China is witnessing a rise in the cases of cardiovascular diseases. In rural and urban areas, cardiovascular disease (CVD) caused 46.74% and 44.26% of all fatalities in 2019. CVD was the cause of two out of every five deaths. In China, there are thought to be 330 million CVD sufferers. India experiences premature death due to cardiovascular disease, responsible for one-fourth of all fatalities. Both rural and urban populations in India are experiencing a sharp surge in hypertension. According to the Sustainable Development Goals, India's National Health Policy intends to reduce premature mortality from non-communicable diseases (NCD) by one-third by 2030. All these factors will help boost the demand in the Asia Pacific region.
The China market dominated the Asia Pacific Hemodynamic Monitoring Devices Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $129.9 Million by 2030. The Japan market is anticipated to grow at a CAGR of 5.5% during (2023 - 2030). Additionally, The India market would witness a CAGR of 6.9% during (2023 - 2030).
Based on Product, the market is segmented into Monitors and Disposables. Based on System Type, the market is segmented into Non-Invasive, Minimally Invasive and Invasive. Based on End Use, the market is segmented into Hospitals, Catheterization Labs, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Hemodynamic Monitoring Devices Market is Projected to reach USD 1.9 Billion by 2030, at a CAGR of 5.4%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, GE HealthCare Technologies, Inc., Baxter International, Inc., ICU Medical, Inc., Masimo Corporation, Deltex Medical Group Plc., Sramek BioDynamics, Inc., Osypka Medical GmbH, Medtronic PLC, and Koninklijke Philips N.V.
By Product (Volume, Thousand Units, USD Million, 2019-2030)
By System Type (Volume, Thousand Units, USD Million, 2019-2030)
By End-use (Volume, Thousand Units, USD Million, 2019-2030)
By Country (Volume, Thousand Units, USD Million, 2019-2030)
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 